# Kiora Pharmaceuticals Inc: Form 8-K, filed May 8, 2026

- Company: [Kiora Pharmaceuticals Inc](/companies/kprx.md) (CIK 1372514)
- Form: 8-K
- Filed: 2026-05-08
- Accepted by EDGAR: May 8, 2026, 07:07 ET
- Period: 2026-05-08
- Accession: 0001372514-26-000048
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1372514/000137251426000048/kprx-20260508.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1372514/000137251426000048/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1372514/000137251426000048/kprx-20260508.htm

Filed May 8, 2026.
Source: SEC EDGAR, the filing index for accession 0001372514-26-000048. Last ingested by Listed: Nov 12, 2026, 17:43 ET. No prices; not investment advice.
